Theoretical Studies of the Chemical Reactivity of a Series of Coumarin Derivatives by the Density Functional Theory

The global descriptors of reactivity such as HOMO and LUMO energies, chemical hardness, electrophilicity, softness and dipole moment are theoretically determined for five coumarin derivatives in this paper. The analysis of the determined descriptors allows us to classify the studied molecules according to their reactivities. Thus, compound M3 is qualified to be the most reactive and the least stable with 3.933 eV as its gap energy ΔEgap. It is at the same time the softest, the best electron donor, the most electrophilic and the most polar molecule. The study of thermodynamic parameters shows that all the reactions of formation of studied coumarin derivatives are exothermic and spontaneous with less disorder. Furthermore, Hirschfield population analysis was carried out in order to locate the reactive sites, that are assumed to be the electrophilic and nucleophilic sites of the molecules. It appears that all the reactive sites are located on carbon atoms except those of molecule M3 which are located on oxygen atoms. Compounds M1 and M2 have the same electrophilic site (C15) and the same nucleophilic site (C13) thereby showing that the methyl group does not have any influence on the reactive site. The electrophilic site of the molecule M3 is located on both the identical oxygen atoms O33 and O34 while its nucleophilic site is located on the oxygen atoms O12. The electrophilic sites of compound M4 and M5 are the same and it is located on carbon atom(C11) while the nucleophilic site is located on carbon atom C23 for molecule M4. Concerning the nucleophilic sites of molecule M5 it is located on carbon atom C20. The difference nucleophilic reactive site may be due to the conjugation of activity of both fluorine atom and methyl group on the M5

The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance

INTRODUCTION Investment in Africa over the past year with regard to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sequencing has led to a massive increase in the number of sequences, which, to date, exceeds 100,000 sequences generated to track the pandemic on the continent. These sequences have profoundly affected how public health officials in Africa have navigated the COVID-19 pandemic. RATIONALE We demonstrate how the first 100,000 SARS-CoV-2 sequences from Africa have helped monitor the epidemic on the continent, how genomic surveillance expanded over the course of the pandemic, and how we adapted our sequencing methods to deal with an evolving virus. Finally, we also examine how viral lineages have spread across the continent in a phylogeographic framework to gain insights into the underlying temporal and spatial transmission dynamics for several variants of concern (VOCs). RESULTS Our results indicate that the number of countries in Africa that can sequence the virus within their own borders is growing and that this is coupled with a shorter turnaround time from the time of sampling to sequence submission. Ongoing evolution necessitated the continual updating of primer sets, and, as a result, eight primer sets were designed in tandem with viral evolution and used to ensure effective sequencing of the virus. The pandemic unfolded through multiple waves of infection that were each driven by distinct genetic lineages, with B.1-like ancestral strains associated with the first pandemic wave of infections in 2020. Successive waves on the continent were fueled by different VOCs, with Alpha and Beta cocirculating in distinct spatial patterns during the second wave and Delta and Omicron affecting the whole continent during the third and fourth waves, respectively. Phylogeographic reconstruction points toward distinct differences in viral importation and exportation patterns associated with the Alpha, Beta, Delta, and Omicron variants and subvariants, when considering both Africa versus the rest of the world and viral dissemination within the continent. Our epidemiological and phylogenetic inferences therefore underscore the heterogeneous nature of the pandemic on the continent and highlight key insights and challenges, for instance, recognizing the limitations of low testing proportions. We also highlight the early warning capacity that genomic surveillance in Africa has had for the rest of the world with the detection of new lineages and variants, the most recent being the characterization of various Omicron subvariants. CONCLUSION Sustained investment for diagnostics and genomic surveillance in Africa is needed as the virus continues to evolve. This is important not only to help combat SARS-CoV-2 on the continent but also because it can be used as a platform to help address the many emerging and reemerging infectious disease threats in Africa. In particular, capacity building for local sequencing within countries or within the continent should be prioritized because this is generally associated with shorter turnaround times, providing the most benefit to local public health authorities tasked with pandemic response and mitigation and allowing for the fastest reaction to localized outbreaks. These investments are crucial for pandemic preparedness and response and will serve the health of the continent well into the 21st century